» Articles » PMID: 36187724

Characterizing Reasons for Stroke Thrombectomy Ineligibility Among Potential Candidates Transferred in a Hub-and-spoke Network

Abstract

Background: Access to endovascular thrombectomy (EVT) is relatively limited. Hub-and-spoke networks seek to transfer appropriate large vessel occlusion (LVO) candidates to EVT-capable hubs. However, some patients are ineligible upon hub arrival, and factors that drive transfer inefficiencies are not well described. We sought to quantify EVT transfer efficiency and identify reasons for EVT ineligibility.

Methods: Consecutive EVT candidates presenting to 25 spokes from 2018-2020 with pre-transfer CTA-defined LVO and ASPECTS ≥6 were identified from a prospectively maintained database. Outcomes of interest included hub EVT, reasons for EVT ineligibility, and 90-day modified Rankin Scale (mRS) ≤2.

Results: Among 258 patients, the median age was 70 years (IQR 60-81); 50% were female. 56% were ineligible for EVT after hub arrival. Cited reasons were large established infarct (49%), mild symptoms (33%), recanalization (6%), distal occlusion (5%), sub-occlusive lesion (3%), and goals of care (3%). Late window patients [last known well (LKW) >6 hours] were more likely to be ineligible (67% vs 43%, P<0.0001). EVT ineligible patients were older (73 vs 68 years, p=0.04), had lower NIHSS (10 vs 16, p<0.0001), longer LKW-hub arrival time (8.4 vs 4.6 hours, p<0.0001), longer spoke Telestroke consult-hub arrival time (2.8 vs 2.2 hours, p<0.0001), and received less intravenous thrombolysis (32% vs 45%, p=0.04) compared to eligible patients. EVT ineligibility independently reduced the odds of 90-day mRS≤2 (aOR=0.26, 95%CI=0.12,0.56; p=0.001) when controlling for age, NIHSS, and LKW-hub arrival time.

Conclusions: Among patients transferred for EVT, there are multiple reasons for ineligibility upon hub arrival, with most excluded for infarct growth and mild symptoms. Understanding factors that drive transfer inefficiencies is important to improve EVT access and outcomes.

Citing Articles

Interfacility Transfer for Thrombectomy: A Promising Therapeutic Window.

Seners P, Baron J, Wouters A, Desilles J, Pico F, Macrez R Stroke. 2024; 56(2):564-574.

PMID: 39502034 PMC: 11772119. DOI: 10.1161/STROKEAHA.124.049167.


Impact and determinants of door in-door out time for stroke thrombectomy transfers in a large hub-and-spoke network.

Ahmed R, Withers J, McIntyre J, Leslie-Mazwi T, Das A, Dmytriw A Interv Neuroradiol. 2024; :15910199241261760.

PMID: 38872477 PMC: 11571713. DOI: 10.1177/15910199241261760.


The Italian hub-and-spoke network for the emergency neurology management.

Micieli G, Cortelli P, Del Sette M, Cavallini A, Zanferrari C, De Falco A Neurol Sci. 2023; 44(11):3929-3937.

PMID: 37326936 DOI: 10.1007/s10072-023-06883-w.


Symmetric collateral pattern on CTA predicts favorable outcomes after endovascular thrombectomy for large vessel occlusion stroke.

Regenhardt R, Lev M, He J, Dmytriw A, Vranic J, Rabinov J PLoS One. 2023; 18(5):e0284260.

PMID: 37141234 PMC: 10159158. DOI: 10.1371/journal.pone.0284260.


Spoke-administered thrombolysis improves large vessel occlusion early recanalization: the real-world experience of a large academic hub-and-spoke telestroke network.

Kraft A, Regenhardt R, Awad A, Rosenthal J, Dmytriw A, Vranic J Stroke Vasc Interv Neurol. 2023; 3(1).

PMID: 36816048 PMC: 9936963. DOI: 10.1161/svin.122.000427.

References
1.
Huo X, Ma G, Zhang X, Pan Y, Tong X, Sun D . Endovascular therapy in acute anterior circulation large vessel occlusive patients with a large infarct core (ANGEL-ASPECT): protocol of a multicentre randomised trial. Stroke Vasc Neurol. 2022; 8(2):169-174. PMC: 10176983. DOI: 10.1136/svn-2022-001865. View

2.
Gonzalez R, Silva G, He J, Sadaghiani S, Wu O, Singhal A . Identifying Severe Stroke Patients Likely to Benefit From Thrombectomy Despite Delays of up to a Day. Sci Rep. 2020; 10(1):4008. PMC: 7055266. DOI: 10.1038/s41598-020-60933-3. View

3.
Goyal M, Demchuk A, Menon B, Eesa M, Rempel J, Thornton J . Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015; 372(11):1019-30. DOI: 10.1056/NEJMoa1414905. View

4.
Yoshimura S, Uchida K, Sakai N, Yamagami H, Inoue M, Toyoda K . Randomized Clinical Trial of Endovascular Therapy for Acute Large Vessel Occlusion with Large Ischemic Core (RESCUE-Japan LIMIT): Rationale and Study Protocol. Neurol Med Chir (Tokyo). 2021; 62(3):156-164. PMC: 8918370. DOI: 10.2176/nmc.rc.2021-0311. View

5.
Boulouis G, Lauer A, Siddiqui A, Charidimou A, Regenhardt R, Viswanathan A . Clinical Imaging Factors Associated With Infarct Progression in Patients With Ischemic Stroke During Transfer for Mechanical Thrombectomy. JAMA Neurol. 2017; 74(11):1361-1367. PMC: 5710581. DOI: 10.1001/jamaneurol.2017.2149. View